Efficacy and safety of a novel therapeutic of natural origin (ntn) in adult patients with lactose intolerance: a multicenter, randomized, crossover, double-blind, placebo-controlled study

HIGHLIGHTS

• who: Corina Pop et al. from the Department of Gastroenterology and Internal Medicine, Clinical Emergency University Hospital, Institut de Recerca (VHIR), Hospital Universitari, Barcelona, Spain have published the Article: Efficacy and Safety of a Novel Therapeutic of Natural Origin (NTN) in Adult Patients with Lactose Intolerance: A Multicenter, Randomized, Crossover, Double-Blind, Placebo-Controlled Study, in the Journal: Foods 2022, 2600 of /2022/
• what: This placebo-controlled study was conducted to investigate the efficacy and safety of NTN for the treatment of lactose intolerance. The study demonstrated that NTN as a primary treatment (comparison between . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.